LXR-623 5363 after which the tumors are

SKU: 55299539424

Pay in 4 interest-free payments of $21.25 Learn more

Live Spec

LXR-623 5363 after which the tumors areLXR623, also known as WAY 252623, is a highly selective and orally bioavailable synthetic modulator of LXR, which demonstrated efficacy for reducing lesion progression in the murine LDLR( ) atherosclerosis model with no associated increase in hepatic lipogenesis either in this model or Syrian hamsters. In nonhuman primates with normal lipid levels, WAY 252623 significantly reduced total (50 55%) and LDL cholesterol (LDLc) (70 77%) in a time and dose

Store: starnailspa.net · Domain: starnailspa.net